Published 2018
| Version v1
Publication
Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected
Creators
- Bonadonna, Patrizia
- Zanotti, Roberta
- Pagani, Mauro
- Bonifacio, Massimiliano
- Scaffidi, Luigi
- Olivieri, Elisa
- Franchini, Maurizio
- Reccardini, Federico
- Costantino, Maria Teresa
- Roncallo, Chiara
- Mauro, Marina
- Boni, Elisa
- Rizzini, Fabio Lodi
- Bilò, Maria Beatrice
- Marcarelli, Anna Rosaria
- Passalacqua, Giovanni
Contributors
Others:
- Bonadonna, Patrizia
- Zanotti, Roberta
- Pagani, Mauro
- Bonifacio, Massimiliano
- Scaffidi, Luigi
- Olivieri, Elisa
- Franchini, Maurizio
- Reccardini, Federico
- Costantino, Maria Teresa
- Roncallo, Chiara
- Mauro, Marina
- Boni, Elisa
- Rizzini, Fabio Lodi
- Bilò, Maria Beatrice
- Marcarelli, Anna Rosaria
- Passalacqua, Giovanni
Description
Up to 75% of patients with severe anaphylactic reactions after Hymenoptera sting are at risk of further severe reactions if re-stung. Venom immunotherapy (VIT) is highly effective in protecting individuals with ascertained Hymenoptera venom allergy (HVA) and previous severe reactions. After a 3- to 5-year VIT course, most patients remain protected after VIT discontinuation. Otherwise, a lifelong treatment should be considered in high-risk patients (eg, in mastocytosis). Several case reports evidenced that patients with mastocytosis and HVA, although protected during VIT, can re-experience severe and sometimes fatal reactions after VIT discontinuation.
Additional details
Identifiers
- URL
- http://hdl.handle.net/11567/920465
- URN
- urn:oai:iris.unige.it:11567/920465
Origin repository
- Origin repository
- UNIGE